Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracey G Simon

Showing results (41-50 of 129) with videos related to

Pageof 13
Sort By:
Obesity (Silver Spring, Md.)|July 27, 2017
Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and DysfunctionTracey G Simon, Daniel G Bamira, Raymond T Chung, et al.
BMC Gastroenterology|November 24, 2021
Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort studyTracey G Simon, Hannes Hagström, Rajani Sharma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2021
Risk of Cancer in Biopsy-Proven Alcohol-Related Liver Disease: A Population-Based Cohort Study of 3410 PersonsHannes Hagström, Maja Thiele, Rajani Sharma, et al.
Journal of Hepatology|July 5, 2021
Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortalityTracey G Simon, Bjorn Roelstraete, Kayla Hartjes, et al.
Metabolism: Clinical and Experimental|April 23, 2021
Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysisAshwini Arvind, Zoe N Memel, Lisa L Philpotts, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 28, 2023
Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort StudyFahim Ebrahimi, Tracey G Simon, Hannes Hagström, et al.
Clinical Epidemiology|March 21, 2023
Development and Validation of a Novel Tool to Predict Model for End-Stage Liver Disease (MELD) Scores in Cirrhosis, Using Administrative DatasetsTracey G Simon, Sebastian Schneeweiss, Richard Wyss, et al.
Plos One|October 26, 2017
The MELD-Plus: A generalizable prediction risk score in cirrhosisUri Kartoun, Kathleen E Corey, Tracey G Simon, et al.
The New England Journal of Medicine|March 12, 2020
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related MortalityTracey G Simon, Ann-Sofi Duberg, Soo Aleman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 12, 2019
Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver DiseaseTracey G Simon, Jacqueline Henson, Stephanie Osganian, et al.
Pageof 13

Showing results (41-50 of 129) with videos related to

Sort By:
Pageof 13
Obesity (Silver Spring, Md.)|July 27, 2017
Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and DysfunctionTracey G Simon, Daniel G Bamira, Raymond T Chung, et al.
BMC Gastroenterology|November 24, 2021
Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort studyTracey G Simon, Hannes Hagström, Rajani Sharma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2021
Risk of Cancer in Biopsy-Proven Alcohol-Related Liver Disease: A Population-Based Cohort Study of 3410 PersonsHannes Hagström, Maja Thiele, Rajani Sharma, et al.
Journal of Hepatology|July 5, 2021
Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortalityTracey G Simon, Bjorn Roelstraete, Kayla Hartjes, et al.
Metabolism: Clinical and Experimental|April 23, 2021
Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysisAshwini Arvind, Zoe N Memel, Lisa L Philpotts, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 28, 2023
Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort StudyFahim Ebrahimi, Tracey G Simon, Hannes Hagström, et al.
Clinical Epidemiology|March 21, 2023
Development and Validation of a Novel Tool to Predict Model for End-Stage Liver Disease (MELD) Scores in Cirrhosis, Using Administrative DatasetsTracey G Simon, Sebastian Schneeweiss, Richard Wyss, et al.
Plos One|October 26, 2017
The MELD-Plus: A generalizable prediction risk score in cirrhosisUri Kartoun, Kathleen E Corey, Tracey G Simon, et al.
The New England Journal of Medicine|March 12, 2020
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related MortalityTracey G Simon, Ann-Sofi Duberg, Soo Aleman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 12, 2019
Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver DiseaseTracey G Simon, Jacqueline Henson, Stephanie Osganian, et al.
Pageof 13